Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimopoulos

Showing results (261-270 of 3,502) with videos related to

Pageof 351
Sort By:
Bone Marrow Transplantation|June 29, 2000
Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agentA Zomas, N Anagnostopoulos, M A Dimopoulos
Oncotarget|November 23, 2018
IMiDs for myeloma induced renal impairmentMaria Gavriatopoulou, Evangelos Terpos, Meletios Athanasios Dimopoulos
Plos Pathogens|April 6, 2012
Dengue virus infection of the Aedes aegypti salivary gland and chemosensory apparatus induces genes that modulate infection and blood-feeding behaviorShuzhen Sim, José L Ramirez, George Dimopoulos
Seminars in Hematology|April 25, 2009
Treatment of relapsed/refractory multiple myelomaEfstathios Kastritis, Antonio Palumbo, Meletios A Dimopoulos
Biomarker Insights|July 7, 2009
Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung CancerGiannis Mountzios, Meletios-Athanasios Dimopoulos, Christos Papadimitriou
BMC Infectious Diseases|May 2, 2015
How to treat fungal infections in ICU patientsDimitrios K Matthaiou, Theodora Christodoulopoulou, George Dimopoulos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Treatment of plasma cell dyscrasias with thalidomide and its derivativesMeletios A Dimopoulos, Athanasios Anagnostopoulos, Donna Weber
International Journal of Cardiology|February 19, 2021
Gender, an additional cardiovascular risk factor?Ana Barradas-Pires, Vennela Boyalla, Konstantinos Dimopoulos
The New England Journal of Medicine|November 15, 2018
Ibrutinib and Rituximab in Waldenström's MacroglobulinemiaMeletios A Dimopoulos, Zeena Salman, Christian Buske
Advances in Chronic Kidney Disease|August 28, 2012
Evolving chemotherapy options for the treatment of myeloma kidney: a 40-year perspectiveEsftathios Kastritis, Meletios A Dimopoulos, Joan Bladé
Pageof 351

Showing results (261-270 of 3,502) with videos related to

Sort By:
Pageof 351
Bone Marrow Transplantation|June 29, 2000
Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agentA Zomas, N Anagnostopoulos, M A Dimopoulos
Oncotarget|November 23, 2018
IMiDs for myeloma induced renal impairmentMaria Gavriatopoulou, Evangelos Terpos, Meletios Athanasios Dimopoulos
Plos Pathogens|April 6, 2012
Dengue virus infection of the Aedes aegypti salivary gland and chemosensory apparatus induces genes that modulate infection and blood-feeding behaviorShuzhen Sim, José L Ramirez, George Dimopoulos
Seminars in Hematology|April 25, 2009
Treatment of relapsed/refractory multiple myelomaEfstathios Kastritis, Antonio Palumbo, Meletios A Dimopoulos
Biomarker Insights|July 7, 2009
Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung CancerGiannis Mountzios, Meletios-Athanasios Dimopoulos, Christos Papadimitriou
BMC Infectious Diseases|May 2, 2015
How to treat fungal infections in ICU patientsDimitrios K Matthaiou, Theodora Christodoulopoulou, George Dimopoulos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Treatment of plasma cell dyscrasias with thalidomide and its derivativesMeletios A Dimopoulos, Athanasios Anagnostopoulos, Donna Weber
International Journal of Cardiology|February 19, 2021
Gender, an additional cardiovascular risk factor?Ana Barradas-Pires, Vennela Boyalla, Konstantinos Dimopoulos
The New England Journal of Medicine|November 15, 2018
Ibrutinib and Rituximab in Waldenström's MacroglobulinemiaMeletios A Dimopoulos, Zeena Salman, Christian Buske
Advances in Chronic Kidney Disease|August 28, 2012
Evolving chemotherapy options for the treatment of myeloma kidney: a 40-year perspectiveEsftathios Kastritis, Meletios A Dimopoulos, Joan Bladé
Pageof 351